Abstract
Common variable immunodeficiency (CVID) is a primary B-cell immunodeficiency disorder, characterized by remarkable hypogammaglobulinemia. The disease can develop at any age without gender predominance. The prevalence of CVID varies widely worldwide. The underlying causes of CVID remain largely unknown; primary B-cell dysfunctions, defects in T cells and antigen-presenting cells are involved. Although some monogenetic defects have been identified in some CVID patients, it is likely that CVID is polygenic. Patients with CVID develop recurrent and chronic infections (e.g., bacterial infections of the respiratory or gastrointestinal tract), autoimmune diseases, lymphoproliferation, malignancies, and granulomatous lesions. Interestingly, autoimmunity can be the only clinical manifestation of CVID at the time of diagnosis and may even develop prior to hypogammaglobulinemia. The diagnosis of CVID is largely based on the criteria established by European Society for Immunodeficiencies and Pan-American Group for Immunodeficiency (ESID/PAGID) and with some recent modifications. The disease can affect multiple organs, including the liver. Clinical features of CVID patients with liver involvement include abnormal liver biochemistries, primarily elevation of alkaline phosphatase (ALP), nodular regenerative hyperplasia (NRH), or liver cirrhosis and its complications. Replacement therapy with immunoglobulin (Ig) and anti-infection therapy are the primary treatment regimen for CVID patients. No specific therapy for liver involvement of CVID is currently available, and liver transplantation is an option only in select cases. The prognosis of CVID varies widely. Further understanding in the etiology and pathophysiology will facilitate early diagnosis and treatments to improve prognosis.
Similar content being viewed by others
Abbreviations
- AIE:
-
Autoimmune enteropathy
- AIHA:
-
Autoimmune hemolytic anemia
- ALP:
-
Alkaline phosphatase
- CID:
-
Combined immunodeficiency
- CVID:
-
Common variable immunodeficiency
- GLILD:
-
Granulomatous and lymphocytic interstitial lung disease
- IBD:
-
inflammatory bowel disease
- ICON:
-
International Consensus Document
- Ig:
-
Immunoglobulin
- IL:
-
Interleukin
- ITP:
-
Idiopathic thrombocytopenia
- IVIG:
-
Intravenous immunoglobulin
- NRH:
-
Nodular regenerative hyperplasia
- PBC:
-
Primary biliary cholangitis
- PSC:
-
Primary sclerosing cholangitis
- r-GT:
-
Gamma glutamyl transpeptidase
- SCIG:
-
Subcutaneous immunoglobulin
- SIgAD:
-
Selective Immunoglobulin A deficiency
- TLR:
-
Toll-like receptor
- Treg cell:
-
Regulatory T cell
- XLA:
-
X-linked agammaglobulinemia
References
Aune TM, Crooke PS 3rd, Patrick AE, Tossberg JT, Olsen NJ, Spurlock CF 3rd (2017) Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants. J Autoimmun 81:99–109
Bao Y, Cao X (2016) Epigenetic control of B cell development and B-cell-related immune disorders. Clin Rev Allergy Immunol 50:301–311
Messina N, Fulford T, O'Reilly L, Loh WX, Motyer JM, Ellis D, McLean C et al (2016) The NF-kappaB transcription factor RelA is required for the tolerogenic function of Foxp3(+) regulatory T cells. J Autoimmun 70:52–62
Saldana JI, Solanki A, Lau CI, Sahni H, Ross S, Furmanski AL, Ono M et al (2016) Sonic hedgehog regulates thymic epithelial cell differentiation. J Autoimmun 68:86–97
Shaabani N, Khairnar V, Duhan V, Zhou F, Tur RF, Haussinger D, Recher M et al (2016) Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation. J Autoimmun 67:82–89
Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Floisand Y, Froland S, Rollag H et al (2014) Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9. Clin Exp Immunol 175:439–448
Taraldsrud E, Fevang B, Jorgensen SF, Moltu K, Hilden V, Tasken K, Aukrust P et al (2017) Defective IL-4 signaling in T cells defines severe common variable immunodeficiency. J Autoimmun 81:110–119
Vignesh P, Rawat A, Singh S (2017) An update on the use of immunomodulators in primary Immunodeficiencies. Clin Rev Allergy Immunol 52:287–303
Wong GK, Heather JM, Barmettler S, Cobbold M (2017) Immune dysregulation in immunodeficiency disorders: the role of T-cell receptor sequencing. J Autoimmun 80:1–9
Salzer U, Warnatz K, Peter HH (2012) Common variable immunodeficiency: an update. Arthritis Res Ther 14:223
Marschall K, Hoernes M, Bitzenhofer-Gruber M, Jandus P, Duppenthaler A, Wuillemin WA, Rischewski J et al (2015) The Swiss National Registry for primary immunodeficiencies: report on the first 6 years’ activity from 2008 to 2014. Clin Exp Immunol 182:45–50
Gathmann B, Grimbacher B, Beaute J, Dudoit Y, Mahlaoui N, Fischer A, Knerr V et al (2009) The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin Exp Immunol 157(Suppl 1):3–11
Boyle JM, Buckley RH (2007) Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol 27:497–502
Ward C, Lucas M, Piris J, Collier J, Chapel H (2008) Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol 153:331–337
Fukushima K, Ueno Y, Kanegane H, Yamagiwa Y, Inoue J, Kido O, Nagasaki F et al (2008) A case of severe recurrent hepatitis with common variable immunodeficiency. Hepatol Res 38:415–420
Daniels JA, Torbenson M, Vivekanandan P, Anders RA, Boitnott JK (2009) Hepatitis in common variable immunodeficiency. Hum Pathol 40:484–488
Macura-Biegun A, Kowalczyk D (2002) Common variable immunodeficiency concomitant with liver cirrhosis—case report. Przegl Lek 59:472–473
Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48
Graziano V, Pecoraro A, Mormile I, Quaremba G, Genovese A, Buccelli C, Paternoster M et al (2017) Delay in diagnosis affects the clinical outcome in a cohort of cvid patients with marked reduction of iga serum levels. Clin Immunol 180:1–4
Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, Reiser V et al (2014) The United Kingdom primary immune deficiency (UKPID) registry: report of the first 4 years’ activity 2008-2012. Clin Exp Immunol 175:68–78
Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, Espinosa-Rosales FJ et al (2016) International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract 4:38–59
Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, Nishikomori R et al (2011) Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol 31:968–976
group. CTFPs. The French national registry of primary immunodeficiency diseases (2010) Clin Immunol 135:264–272
Xiao X, Miao Q, Chang C, Gershwin ME, Ma X (2014) Common variable immunodeficiency and autoimmunity—an inconvenient truth. Autoimmun Rev 13:858–864
Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C (2012) Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119:1650–1657
Gathmann B, Mahlaoui N, Gerard L, Oksenhendler E, Warnatz K, Schulze I, Kindle G et al (2014) Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 134:116–126
Cunningham-Rundles C, Maglione PJ (2012) Common variable immunodeficiency. J Allergy Clin Immunol 129:1425–1426.e1423
Tseng CW, Lai KL, Chen DY, Lin CH, Chen HH (2015) The incidence and prevalence of common variable immunodeficiency disease in Taiwan, A population-based study. PLoS One 10:e0140473
Oksenhendler E, Gerard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, Viallard JF et al (2008) Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 46:1547–1554
Groth C, Drager R, Warnatz K, Wolff-Vorbeck G, Schmidt S, Eibel H, Schlesier M et al (2002) Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 129:133–139
van de Ven AA, Compeer EB, van Montfrans JM, Boes M (2011) B-cell defects in common variable immunodeficiency: BCR signaling, protein clustering and hardwired gene mutations. Crit Rev Immunol 31:85–98
Foerster C, Voelxen N, Rakhmanov M, Keller B, Gutenberger S, Goldacker S, Thiel J et al (2010) B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiency. J Immunol 184:7305–7313
Ahn S, Cunningham-Rundles C (2009) Role of B cells in common variable immune deficiency. Expert Rev Clin Immunol 5:557–564
Sharifi L, Mirshafiey A, Rezaei N, Azizi G, Magaji Hamid K, Amirzargar AA, Asgardoon MH et al (2016) The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency. Expert Rev Clin Immunol 12:195–207
Yu JE, Knight AK, Radigan L, Marron TU, Zhang L, Sanchez-Ramon S, Cunningham-Rundles C (2009) Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol 124:349-356–e341-343
Yu JE, Zhang L, Radigan L, Sanchez-Ramon S, Cunningham-Rundles C (2012) TLR-mediated B cell defects and IFN-alpha in common variable immunodeficiency. J Clin Immunol 32:50–60
Ochtrop ML, Goldacker S, May AM, Rizzi M, Draeger R, Hauschke D, Stehfest C et al (2011) T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. Blood 118:309–318
Vodjgani M, Aghamohammadi A, Samadi M, Moin M, Hadjati J, Mirahmadian M, Parvaneh N et al (2007) Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J Investig Allergol Clin Immunol 17:321–328
Sanchez-Ramon S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C (2008) Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol 128:314–321
Ko J, Radigan L, Cunningham-Rundles C (2005) Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol 116:37–41
Haymore BR, Mikita CP, Tsokos GC (2008) Common variable immune deficiency (CVID) presenting as an autoimmune disease: role of memory B cells. Autoimmun Rev 7:309–312
Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M et al (2008) The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111:77–85
Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, Debre P et al (2003) Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23:385–400
Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, Eibel H et al (2002) Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99:1544–1551
Azizi G, Abolhassani H, Asgardoon MH, Alinia T, Yazdani R, Mohammadi J, Rezaei N et al (2017) Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol 13:101–115
Azizi G, Rezaei N, Kiaee F, Tavakolinia N, Yazdani R, Mirshafiey A, Aghamohammadi A (2016) T-cell abnormalities in common variable immunodeficiency. J Investig Allergol Clin Immunol 26:233–243
Berron-Ruiz L, Lopez-Herrera G, Vargas-Hernandez A, Santos-Argumedo L, Lopez-Macias C, Isibasi A, Segura-Mendez NH et al (2016) Impaired selective cytokine production by CD4(+) T cells in common variable immunodeficiency associated with the absence of memory B cells. Clin Immunol 166-167:19–26
Yu GP, Chiang D, Song SJ, Hoyte EG, Huang J, Vanishsarn C, Nadeau KC (2009) Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin Immunol 131:240–253
Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, Fieschi C et al (2008) Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112:277–286
Malphettes M, Gerard L, Carmagnat M, Mouillot G, Vince N, Boutboul D, Berezne A et al (2009) Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 49:1329–1338
Yong PF, Workman S, Wahid F, Exley A, Webster AD, Ibrahim MA (2008) Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency. Clin Immunol 127:34–42
Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Galicier L, Lepelletier Y, Webster D, Levy Y et al (2004) Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 104:2441–2443
Ochs HD (2014) Common variable immunodeficiency (CVID): new genetic insight and unanswered questions. Clin Exp Immunol 178(Suppl 1):5–6
Bogaert DJ, Dullaers M, Lambrecht BN, Vermaelen KY, De Baere E, Haerynck F (2016) Genes associated with common variable immunodeficiency: one diagnosis to rule them all? J Med Genet 53:575–590
Kotlarz D, Zietara N, Milner JD, Klein C (2014) Human IL-21 and IL-21R deficiencies: two novel entities of primary immunodeficiency. Curr Opin Pediatr 26:704–712
Abolhassani H, Wang N, Aghamohammadi A, Rezaei N, Lee YN, Frugoni F, Notarangelo LD et al (2014) A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol 134:1375–1380
Sekinaka Y, Mitsuiki N, Imai K, Yabe M, Yabe H, Mitsui-Sekinaka K, Honma K, et al (2017) Common variable immunodeficiency caused by FANC mutations. J Clin Immunol 37:434–444
Cunningham-Rundles C (2010) How I treat common variable immune deficiency. Blood 116:7–15
Li J, Wei Z, Li YR, Maggadottir SM, Chang X, Desai A, Hakonarson H (1860) Understanding the genetic and epigenetic basis of common variable immunodeficiency disorder through omics approaches. Biochim Biophys Acta 2016:2656–2663
Fernandez Romero DS, Juri MC, Paolini MV, Malbran A (2013) Common variable immunodeficiency. Epidemiology and clinical manifestations in 69 patients. Medicina B Aires 73:315–323
Busse PJ, Farzan S, Cunningham-Rundles C (2007) Pulmonary complications of common variable immunodeficiency. Ann Allergy Asthma Immunol 98:1–8 quiz 8-11, 43
Atarod L, Raissi A, Aghamohammadi A, Farhoudi A, Khodadad A, Moin M, Pourpak Z et al (2003) A review of gastrointestinal disorders in patients with primary antibody immunodeficiencies during a 10-year period (1990-2000), in children hospital medical center. Iran J Allergy Asthma Immunol 2:75–79
Kralickova P, Mala E, Vokurkova D, Krcmova I, Pliskova L, Stepanova V, Bartos V et al (2014) Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports. Int Arch Allergy Immunol 163:69–74
Woodward J, Gkrania-Klotsas E, Kumararatne D (2017) Chronic norovirus infection and common variable immunodeficiency. Clin Exp Immunol 188:363–370
Herrera-Sanchez DA, Castilla-Rodriguez JL, Castrejon-Vazquez MI, Vargas-Camano ME, Medina-Torres EA, Blancas-Galicia L, Espinosa-Padilla SE (2015) Infection due to Mycobacterium bovis in common variable immunodeficiency. Rev Alerg Mex 62:75–82
Milligan KL, Jain AK, Garrett JS, Knutsen AP (2012) Gastric ulcers due to varicella-zoster reactivation. Pediatrics 130:e1377–e1381
Cunningham-Rundles C (2008) Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol 28(Suppl 1):S42–S45
Agarwal S, Cunningham-Rundles C (2009) Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep 9:347–352
Martin-Blondel G, Camara B, Selves J, Robic MA, Thebault S, Bonnet D, Alric L (2010) Etiology and outcome of liver granulomatosis: a retrospective study of 21 cases. Rev Med Interne 31:97–106
Unger S, Seidl M, van Schouwenburg P, Rakhmanov M, Bulashevska A, Frede N, Grimbacher B et al (2017) TH1 phenotype of T follicular helper cells indicates an IFNgamma-associated immune dysregulation in CD21low CVID patients. J Allergy Clin Immunol
Patuzzo G, Barbieri A, Tinazzi E, Veneri D, Argentino G, Moretta F, Puccetti A et al (2016) Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmun Rev 15:877–882
Keller B, Stumpf I, Strohmeier V, Usadel S, Verhoeyen E, Eibel H, Warnatz K (2017) High SYK expression drives constitutive activation of CD21low B cells. J Immunol 198:4285–4292
Wehr C, Eibel H, Masilamani M, Illges H, Schlesier M, Peter HH, Warnatz K (2004) A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol 113:161–171
Chua I, Quinti I, Grimbacher B (2008) Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics. Curr Opin Hematol 15:368–374
Abolhassani H, Aghamohammadi A, Imanzadeh A, Mohammadinejad P, Sadeghi B, Rezaei N (2012) Malignancy phenotype in common variable immunodeficiency. J Investig Allergol Clin Immunol 22:133–134
Reichenberger F, Wyser C, Gonon M, Cathomas G, Tamm M (2001) Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome. Respiration 68:109–112
da Silva SP, Resnick E, Lucas M, Lortan J, Patel S, Cunningham-Rundles C, Gatter K et al (2011) Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events. J Clin Immunol 31:784–791
Cunningham-Rundles C, Cooper DL, Duffy TP, Strauchen J (2002) Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol 69:171–178
Gangemi S, Allegra A, Musolino C (2015) Lymphoproliferative disease and cancer among patients with common variable immunodeficiency. Leuk Res 39:389–396
Quinti I, Agostini C, Tabolli S, Brunetti G, Cinetto F, Pecoraro A, Spadaro G (2012) Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency. Blood 120:1953–1954
Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H (2011) Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol 165:1–7
Gemeinhardt M, Turck J, Piper B, Helmberger T, Nerlich A, Schepp W (2012) Adenocarcinoma of the stomach and neuroendocrine carcinoma of the colon in a 45-year-old male patient suffering from common variable immunodeficiency (CVID) and ulcerative colitis. Z Gastroenterol 50:1292–1295
Ardeniz O, Cunningham-Rundles C (2009) Granulomatous disease in common variable immunodeficiency. Clin Immunol 133:198–207
Morimoto Y, Routes JM (2005) Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 5:370–375
Verbsky JW, Routes JM (2014) Sarcoidosis and common variable immunodeficiency: similarities and differences. Semin Respir Crit Care Med 35:330–335
Agarwal S, Mayer L (2013) Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol 11:1050–1063
Daniels JA, Lederman HM, Maitra A, Montgomery EA (2007) Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 31:1800–1812
Goel A, Elias JE, Eapen CE, Ramakrishna B, Elias E (2014) Idiopathic non-cirrhotic intrahepatic portal hypertension (NCIPH)-newer insights into pathogenesis and emerging newer treatment options. J Clin Exp Hepatol 4:247–256
Gandhi K, Parikh P, Aronow WS, Desai H, Amin H, Sharma M, Rubinstein A (2010) A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID). J Gastrointest Cancer 41:281–284
Malamut G, Ziol M, Suarez F, Beaugrand M, Viallard JF, Lascaux AS, Verkarre V et al (2008) Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 48:74–82
Fuss IJ, Friend J, Yang Z, He JP, Hooda L, Boyer J, Xi L et al (2013) Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol 33:748–758
Manas MD, Marchan E, Gijon J, Martin F (2006) Nodular regenerative hyperplasia of the liver in a patient with common variable immunodeficiency. An Med Interna 23:395–397
Conley ME, Park CL, Douglas SD (1986) Childhood common variable immunodeficiency with autoimmune disease. J Pediatr 108:915–922
Hausser C, Virelizier JL, Buriot D, Griscelli C (1983) Common variable hypogammaglobulinemia in children. Clinical and immunologic observations in 30 patients. Am J Dis Child 137:833–837
Martire B, Gentile A, Francavilla R, De Santis A, De Mattia D (2005) Successful treatment with cyclosporine A of HCV-driven chronic liver disease mimicking autoimmune hepatitis in a patient with common variable immunodeficiency. Immunopharmacol Immunotoxicol 27:535–543
Mahdavinia M, Mirsaeidi M, Bishehsari F, McGrath K (2015) Primary sclerosing cholangitis in common variable immune deficiency. Allergol Int 64:187–189
Holmes SN, Condliffe A, Griffiths W, Baxendale H, Kumararatne DS (2015) Familial hepatopulmonary syndrome in common variable immunodeficiency. J Clin Immunol 35:302–304
Schouten JN, Verheij J, Seijo S (2015) Idiopathic non-cirrhotic portal hypertension: a review. Orphanet J Rare Dis 10:67
Webb GJ, Hirschfield GM (2016) Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun 66:25–39
Conley ME, Notarangelo LD, Etzioni A (1999) Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93:190–197
Chapel H (2016) Common variable immunodeficiency disorders (CVID)—diagnoses of exclusion, especially combined immune defects. J Allergy Clin Immunol Pract 4:1158–1159
Bertinchamp R, Gerard L, Boutboul D, Malphettes M, Fieschi C, Oksenhendler E (2016) Exclusion of patients with a severe T-cell defect improves the definition of common variable immunodeficiency. J Allergy Clin Immunol Pract 4:1147–1157
Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L et al (2007) Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120:776–794
Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C et al (2015) Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol 35:696–726
Chapel H, Cunningham-Rundles C (2009) Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 145:709–727
Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R (2013) New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol 174:203–211
Ameratunga R, Gillis D, Steele R (2016) Diagnostic criteria for common variable immunodeficiency disorders. J Allergy Clin Immunol Pract 4:1017–1018
Ameratunga R, Brewerton M, Slade C, Jordan A, Gillis D, Steele R, Koopmans W et al (2014) Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol 5:415
Al Kindi M, Mundy J, Sullivan T, Smith W, Kette F, Smith A, Heddle R et al (2012) Utility of peripheral blood B cell subsets analysis in common variable immunodeficiency. Clin Exp Immunol 167:275–281
Szablewski V, Rene C, Costes V (2015) Indolent cytotoxic T cell lymphoproliferation associated with nodular regenerative hyperplasia: a common liver lesion in the context of common variable immunodeficiency disorder. Virchows Arch 467:733–740
Ravindran J, Gillis D, Rowland R, Heddle R (1995) Common variable immunodeficiency associated with nodular regenerative hyperplasia of the liver. Aust NZ J Med 25:741
Kasztalska K, Ciebiada M, Cebula-Obrzut B, Gorski P (2011) Intravenous immunoglobulin replacement therapy in the treatment of patients with common variable immunodeficiency disease: an open-label prospective study. Clin Drug Investig 31:299–307
Albin S, Cunningham-Rundles C (2014) An update on the use of immunoglobulin for the treatment of immunodeficiency disorders. Immunotherapy 6:1113–1126
Eijkhout HW, van Der Meer JW, Kallenberg CG, Weening RS, van Dissel JT, Sanders LA, Strengers PF et al (2001) The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med 135:165–174
Stonebraker JS, Farrugia A, Gathmann B, Orange JS (2014) Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulin. J Clin Immunol 34:233–244
Bjoro K, Haaland T, Skaug K, Froland SS (1999) The spectrum of hepatobiliary disease in primary hypogammaglobulinaemia. J Intern Med 245:517–524
Wong GK, Goldacker S, Winterhalter C, Grimbacher B, Chapel H, Lucas M, Alecsandru D et al (2013) Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients. Clin Exp Immunol 172:63–72
Boursiquot JN, Gerard L, Malphettes M, Fieschi C, Galicier L, Boutboul D, Borie R et al (2013) Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol 33:84–95
Thatayatikom A, Thatayatikom S, White AJ (2005) Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 95:293–300
Malphettes M, Oksenhendler E, Galicier L, Fieschi C (2008) Granulomatous disease in common variable immunodeficiency. Rev Med Interne 29:28–32
Franxman TJ, Howe LE, Baker JR Jr (2014) Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency. J Clin Immunol 34:820–827
Chen Y, Cameron A (2013) Aspergillosis after liver transplantation in the context of common variable immunodeficiency: case report. Transpl Infect Dis 15:540–544
Montalti R, Mocchegiani F, Vincenzi P, Svegliati Baroni G, Nicolini D, Vivarelli M (2014) Liver transplantation in patients with common variable immunodeficiency: a report of two cases. Ann Transplant 19:541–544
Murakawa Y, Miyagawa-Hayashino A, Ogura Y, Egawa H, Okamoto S, Soejima Y, Kurosawa M et al (2012) Liver transplantation for severe hepatitis in patients with common variable immunodeficiency. Pediatr Transplant 16:E210–E216
Smith MS, Webster AD, Dhillon AP, Dusheiko G, Boulton R, Savage K, Rolles K et al (1995) Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency. Gastroenterology 108:879–884
Rizzi M, Neumann C, Fielding AK, Marks R, Goldacker S, Thaventhiran J, Tarzi MD et al (2011) Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J Allergy Clin Immunol 128:1371–1374.e1372
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This article does not contain any studies with human participants or animals performed by any of the authors.
The authors declare that they have no potential conflict of interest.
Rights and permissions
About this article
Cite this article
Song, J., Lleo, A., Yang, G.X. et al. Common Variable Immunodeficiency and Liver Involvement. Clinic Rev Allerg Immunol 55, 340–351 (2018). https://doi.org/10.1007/s12016-017-8638-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-017-8638-z